COGT
Price:
$33.1
Market Cap:
$5.66B
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, ...[Read more]
Industry
Biotechnology
IPO Date
2018-03-29
Stock Exchange
NASDAQ
Ticker
COGT
According to Cogent Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 15.14. This represents a change of 51.59% compared to the average of 9.99 of the last 4 quarters.
The mean historical Current Ratio of Cogent Biosciences, Inc. over the last ten years is 8.63. The current 15.14 Current Ratio has changed 17.43% with respect to the historical average. Over the past ten years (40 quarters), COGT's Current Ratio was at its highest in in the March 2021 quarter at 28.16. The Current Ratio was at its lowest in in the September 2015 quarter at 0.
Average
8.63
Median
7.54
Minimum
3.06
Maximum
18.70
Discovering the peaks and valleys of Cogent Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 510.46%
Maximum Annual Current Ratio = 18.70
Minimum Annual Increase = -52.55%
Minimum Annual Current Ratio = 3.06
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 14.23 | 167.48% |
| 2024 | 5.32 | -24.99% |
| 2023 | 7.09 | -28.11% |
| 2022 | 9.87 | -24.30% |
| 2021 | 13.04 | -30.30% |
| 2020 | 18.70 | 510.46% |
| 2019 | 3.06 | -5.64% |
| 2018 | 3.25 | -14.26% |
| 2017 | 3.79 | -52.55% |
| 2016 | 7.98 | -36.12% |
The current Current Ratio of Cogent Biosciences, Inc. (COGT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.88
5-year avg
9.91
10-year avg
8.63
Cogent Biosciences, Inc.’s Current Ratio is greater than Arcus Biosciences, Inc. (4.04), greater than ImmunityBio, Inc. (6.67), greater than Denali Therapeutics Inc. (9.28), less than 89bio, Inc. (15.19), less than Galapagos N.V. (30.48), greater than Liquidia Corporation (2.22), greater than Ocular Therapeutix, Inc. (14.81), greater than Agios Pharmaceuticals, Inc. (14.19), less than Viridian Therapeutics, Inc. (15.15), greater than Recursion Pharmaceuticals, Inc. (5.47),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.04 | $2.40B | |
| 6.67 | $7.44B | |
| 9.28 | $3.44B | |
| 15.19 | $2.20B | |
| 30.48 | $1.84B | |
| 2.22 | $6.33B | |
| 14.81 | $1.96B | |
| 14.19 | $1.75B | |
| 15.15 | $1.47B | |
| 5.47 | $1.41B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cogent Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cogent Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Cogent Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Cogent Biosciences, Inc. (COGT)?
What is the highest Current Ratio for Cogent Biosciences, Inc. (COGT)?
What is the 3-year average Current Ratio for Cogent Biosciences, Inc. (COGT)?
What is the 5-year average Current Ratio for Cogent Biosciences, Inc. (COGT)?
How does the current Current Ratio for Cogent Biosciences, Inc. (COGT) compare to its historical average?